Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment
Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment
Recruiting · NCT04396223 · Registry updated 2024-02-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment | Gestational Trophoblastic Neoplasias (GTN) | Recruiting | Phase 1 / Phase 2 | 2024-02-29 | NCT04396223 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospices Civils de Lyon | 429 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 18 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Assistance Publique Hôpitaux De Paris | Paris | France | 3 |
| Centre Antoine Lacassagne | Nice | France | 5 |
| Centre Eugène Marquis | Rennes | France | 13 |
| Centre François Baclesse | Caen | France | 23 |
| Centre Hospitalier Lyon Sud | Pierre-Bénite | France | 1 |
| Centre Oscar Lambret | Lille | France | 41 |
| Institut Bergonié | Bordeaux | France | 14 |
| Institut Paoli-Calmettes | Marseille | France | 1 |
| Institut Universitaire du Cancer de Toulouse - Oncopole | Toulouse | France | 1 |